Summary
The growth factor-activated mitogenic pathways are often disregulated in tumour cells and, therefore, they can provide specific molecular targets for novel anti-tumour approaches. 8-Chloro-cAMP (8-Cl-cAMP), a synthetic cAMP analogue, is a novel anti-tumour agent that has recently undergone clinical evaluation. We investigated the effects of 8-CI-cAMP on the epidermal growth factor (EGF)/EGF receptor (EGF-R) signalling in human epidermoid cancer KB cells, which are responsive to the mitogenic stimulus of EGF. We found that the growth-promoting activity of EGF was completely abolished when EGF treatment was performed in combination with 8-CI-cAMP. The inhibition of the EGF-induced proliferation by 8-CI-cAMP was paralleled by the blockade of the EGF-stimulated activation of mitogen-activated protein kinases (MAPK), ERK-1 and ERK-2. Conversely, we found an increase of EGF-R expression and EGF-R tyrosine phosphorylation when KB cells were growth inhibited by 8-Cl-cAMP. Moreover, the activity of Raf-1 and MEK-1 protein kinases, the activators upstream MAPK in the phosphorylation cascade induced by EGF, was not modified in 8-Cl-cAMP-treated cells. We concluded that the impairment of KB cell response to EGF, induced by 8-Cl-cAMP, resides in the specific inhibition of MAPK/ERKs activity while the function of the upstream elements in the EGF-R signalling is preserved.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Aboud-Pirak, E, Hurwitz, E, Pirak, ME, Bellot, F, Schlessinger, J & Sela, M (1988). Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. J Natl Cancer Inst 80: 1605–1611.
Bianco, C, Tortora, G, Baldassarre, G, Caputo, R, Fontanini, G, Chinè, S, Bianco, AR & Ciardiello, F (1997). 8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer. Clin Cancer Res 3: 439–448.
Bosanquet, AG, Buriton, AR, Bell, PB & Harris, AL (1997). Ex vivo cytotoxic drug evalutation by DISC assay to expedite identification of clinical targets: results with 8-chloro-cAMP. Br J Cancer 76: 511–518.
Budillon, A, Tagliaferri, P, Caraglia, M, Torrisi, MR, Normanno, N, Iacobelli, S, Palmieri, G, Stoppelli, MP, Frati, L & Bianco, AR (1991). Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells. Cancer Res 51: 1294–1299.
Budillon, A, Cereseto, A, Kondrashin, A, Nesterova, M, Merlo, G, Clair, T & Cho-Chung, YS (1995). Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RIIβ regulatory subunit to lose its ability to revert transformed fibroblasts. Proc Natl Acad Sci USA 92: 10634–10638.
Caraglia, M, Tagliaferri, P, Correale, P, Genua, G, Pinto, A, Esposito, G & Bianco, AR (1993). Cytosine arabinoside increases the binding of [125I]-labelled epidermal growth factor and [125I]-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb. Cancer Immunol Immunother 37: 150–156.
Caraglia, M, Leardi, A, Ciardiello, F, Budillon, A, Guarrasi, R, Bianco, AR & Tagliaferri, P (1995). α-Interferon potentiates epidermal growth factor receptor-mediated effects on human epidermoid carcinoma KB cells. Int J Cancer 61: 342–347.
Caraglia, M, Di Gennaro, E, Barbarulo, D, Marra, M, Tagliaferri, P, Abbruzzese, A & Budillon, A (1999). Upregulated EGF receptors undergo to rapid internalization and ubiquitin-dependent degradation in human cancer cells exposed to 8-Cl-cAMP. FEBS Lett 447: 203
Cho-Chung, YS (1989). Site-selective 8-chloro-cyclic adenosine 3′,5′-monophosphate as a biologic modulator of cancer: restoration of normal control mechanisms. J Natl Cancer Inst 81: 982–987.
Cho-Chung, YS, Pepe, S, Clair, T, Budillon, A & Nesterova, M (1995). cAMP-dependent protein kinase: role in normal and malignant growth. Crit Rev Oncol Hematol 21: 33–61.
Ciardiello, F, Damiano, V, Bianco, R, Bianco, C, Fontanini, G, De Laurentis, M, De Placido, S, Mendelsohn, J, Bianco, AR & Tortora, G (1996). Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. J Natl Cancer Inst 88: 1770–1776.
Cook, SJ & McCormick, F (1993). Inhibition by cAMP of Ras-dependent activation of Raf. Science 262: 1069–1072.
Crews, CM & Erikson, RL (1993). Extracellular signals and reversible protein phosphorylation: what to MEK of it all. Cell 74: 215–217.
Csar, XF, Ward, AC, Hoffmann, BW, Guy, GG & Hamilton, JA (1997). cAMP suppresses p21ras and Raf-1 responses but not the Erk-1 response to granulocyte-colony-stimulating factor: possible Raf-1-independent activation of Erk-1. Biochem J 322: 79–87.
Denhardt, DT (1996). Signal-transduction protein phosphorylation cascades mediated by ras/rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem J 318: 729–747.
Faure, M & Bourne, HR (1995). Differential effects of cAMP on the MAP kinase cascade: evidence for a cAMP-insensitive step that can bypass Raf-1. Mol Biol Cell 6: 1025–1035.
Fassina, G, Aluigi, MG, Gentleman, S, Wong, P, Cai, T, Albini, A & Noonan, DM (1997). The cAMP analog 8-Cl-cAMP inhibits growth and induces differentiation and apoptosis in retinoblastoma cells. Int J Cancer 72: 1088–1094.
Frodin, M, Peraldi, P & Van Obberghen, E (1994). Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J Biol Chem 269: 6207–6214.
Hordijk, PL, Verlaan, I, Jalink, K & Moolenaar, WH (1994). cAMP abrogates the p21ras-mitogen-activated protein kinase pathway in fibroblasts. J Biol Chem 269: 3534–3538.
Huang, PS & Heimbrook, DC (1997). Oncogene products as therapeutic targets for cancer. Curr Opin Oncol 9: 94–100.
Jetten, AM (1980). Retinoids specifically enhance the number of epidermal growth factor receptors. Nature (Lond) 284: 626–629.
Kharbanda, S, Saleem, A, Emoto, Y, Stone, R, Rapp, U & Kufe, D (1994). Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cells. J Biol Chem 269: 872–878.
Lange-Carter, CA, Vuillequez, JJ & Malkinson, AM (1993). 8-Chloro-adenosine mediates 8-chloro-cyclic AMP-induced down-regulation of cyclic AMP-dependent protein kinase in normal and neoplastic mouse lung epithelial cells by a cyclic AMP-independent mechanism. Cancer Res 53: 393–400.
Langeveld, CH, Jongenelen, CA, Theeuwes, JW, Baak, JP, Heimans, JJ, Stoof, JC & Peters, GJ (1997). The antiproliferative effect of 8-chloro-adenosine, an active metabolite of 8-chloro-cyclic adenosine monophosphate, and disturbances in nucleic acid synthesis and cell cycle kinetics. Biochem Pharmacol 53: 141–148.
Langdon, SP, Ritchie, AA, Muir, M, Dodds, M, Howie, AF, Leonard, RC, Stockman, PK & Miller, WR (1998). Antitumour activity and schedule dependency of 8-chloro-adenosine- 3′,5′-monophosphate (8-Cl-cAMP) against human tumour xenografts. Eur J Cancer 34: 384–388.
Marshall, CJ (1994). MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Genet Dev 4: 82–89.
Marshall, CJ (1996). Raf gets it together. Nature (Lond) 383: 127–128.
McKenzie, FR & Pouysségur, J (1996). cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. J Biol Chem 271: 13476–13483.
Miller, WR, Hulme, MJ, Cho-Chung, YS & Elton, RA (1993). Types of cyclic AMP binding proteins in human breast cancers. Eur J Cancer 29: 989–991.
Noguchi, K, Murata, T & Cho-Chung, YS (1998). 8-chloroadenosine 3′,5′-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase A type I to induce growth inhibition in c-ras-transformed fibroblasts. Eur J Cancer 34: 1260–1267.
Rohlff, C, Clair, T & Cho-Chung, YS (1993). 8-Cl-cAMP induces truncation and down-regulation of the RI alpha subunit and up-regulation of the RII beta subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells. J Biol Chem 268: 5774–5782.
Saunders, MP, Salisbury, AJ, O’Byrne, KJ, Long, L, Whitehouse, RM, Talbot, DC, Mawer, EB & Harris, AL (1997). A novel cyclic adenosine monophosphate analog induces hypercalcemia via production of 1,25-dihydroxyvitamin D in patients with solid tumors. J Clin Endocrinol Metab Dec 82: 4044–4048.
Scala, S, Budillon, A, Zhan, Z, Cho-Chung, YS, Jefferson, J, Tsokos, M & Bates, SE (1995). Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells. J Clin Inv 96: 1026–1034.
Schwartz, DA & Rubin, CS (1985). Identification and differential expression of two forms of regulatory subunits (RII) of cAMP-dependent protein kinase II in Friend erythroleukemic cells Differentiation and 8-bromo-cAMP elicit a large and selective increase in the rate of biosynthesis of only one type of RII. J Biol Chem 260: 6296–6303.
Tagliaferri, P, Caraglia, M, Muraro, R, Pinto, A, Budillon, A, Zagonel, V & Bianco, AR (1994). Pharmacological modulation of peptide growth factor receptor expression on tumor cells as a basis for cancer therapy. Anticancer Drugs 5: 379–393.
Tagliaferri, P, Katsaros, D, Clair, T, Neckers, L, Ally, S, Tortora, G, Neckers, L, Rubalcava, B, Parandoosh, Z, Chang, YA, Revankar, GR & Cho-Chung, YS (1988). Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues. Cancer Res 48: 1642–1650.
Tortora, G, Ciardiello, F, Pepe, S, Tagliaferri, P, Ruggiero, A, Bianco, C, Guarrasi, R, Miki, K & Bianco, AR (1995). Phase I clinical study with 8-chloro-cAMP and evaluation of immunological effects in cancer patients. Clin Cancer Res 1: 377–384.
Tortora, G, Damiano, V, Bianco, C, Baldassarre, G, Bianco, AR, Lanfrancone, L, Pelicci, PG & Ciardiello, F (1997a). The RIα subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor. Oncogene 14: 923–928.
Tortora, G, Di Isernia, G, Sandomenico, C, Bianco, R, Pomatico, G, Pepe, S, Bianco, AR & Ciardiello, F (1997b). Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cell. Cancer Res 57: 5107–5111.
Tortora, G, Pepe, S, Cirafici, AM, Ciardiello, F, Porcellini, A, Clair, T, Colletta, G, Cho-Chung, YS & Bianco, AR (1993). Thyroid-stimulating hormone-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cyclic AMP-dependent protein kinase. Cell Growth Differ 4: 359–365.
Ullrich, A & Schlessinger, J (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203–212.
Vossler, MR, Yao, H, York, RD, Pan, MG, Rim, CS & Stork, PJ (1997). cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap 1-dependent pathway. Cell 89: 73–82.
Withers, DJ, Bloom, SR & Rozengurt, E (1995). Dissociation of cAMP-stimulated mitogenesis from activation of the mitogen-activated protein kinase cascade in Swiss 3T3 cells. J Biol Chem 270: 21411–21419.
Wu, J, Dent, P, Jelinek, T, Wolfman, A, Weber, MJ & Sturgill, TW (1993). Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262: 1065–1069.
Zuckier, G & Tritton, TR (1983). Adriamycin causes up regulation of epidermal growth factor receptors in actively growing cells. Exp Cell Res 148: 155–161.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Budillon, A., Gennaro, E., Caraglia, M. et al. 8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor. Br J Cancer 81, 1134–1141 (1999). https://doi.org/10.1038/sj.bjc.6690820
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690820
